Sort
82,697 grants matching “vaccine development”
Industrialization Core: Production of monoclonal antibodies and product developm
$1,357,509Larry Zeitlin · Scripps Research Institute, The · U19 · FY2015 · AI
Rational design and efficacy testing of vaccines against HCV
$1,357,012Thomas R Fuerst · Univ Of Maryland, College Park · R01 · FY2025 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2023 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2022 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2024 · AI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
$1,357,000Chiung-Yu Hung · University Of Texas San Antonio · U19 · FY2025 · AI
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,356,966Reed Johnson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Membrane Remodeling in Viral Infection and Viral Assembly
$1,356,672Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Macque
$1,356,231Francois J Villinger · Emory University · U19 · FY2013 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,356,084Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
2/2 CCNY-MSKCC Partnership for Cancer Research, Education and Community Outreach
$1,356,036Tim Alan Ahles · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Disseminated Tuberculosis in HIV Infection
$1,356,004Dartmouth College · U01 · FY2005 · AI
A Pilot Trial of the effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
$1,355,943David M. Margolis · Univ Of North Carolina Chapel Hill · U01 · FY2019 · AI
SBIR Phase II: Anti-Tumor Immune Redirectors (AIRs) for cancer treatment
$1,355,844Joshua Wang · Verimmune Inc. · · FY2020 · TIP
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,355,835Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Midwest STIs Topical Microbicide Cooperative Research
$1,355,808Indiana Univ-Purdue Univ At Indianapolis · U19 · FY2004 · AI
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$1,355,719Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Combined Approach to Broadly Protective AIDS Vaccines
$1,355,705University Of Washington · P01 · FY2003 · AI
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,355,530Vanderbilt University · U01 · FY2003 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$1,355,477Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
$1,355,090National Institute Of Allergy And Infectious Diseases · Y01 · FY2009 · AI
Subcellular protein localization in B. subtilis
$1,354,767Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
$1,354,347Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2008 · AI
Immunobiology and immunotherapy of leukemia
$1,353,837Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Characterization and improvement of graft versus leukemia effects
$1,353,837Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL